Nutil

Recreational Drugs

Information on common substances

Cannabis

How It Works

Known Risks

Medical Use

MDMA (Ecstasy)

How It Works

Known Risks

Harm Reduction

Opioids

How They Work

Overdose Risk

Treatment

Cocaine

How It Works

Known Risks

Stimulants (Amphetamines/Methamphetamine)

How They Work

Known Risks

Psychedelics

How They Work

Therapeutic Potential

Risks

Nicotine

How It Works

Health Effects

Quitting

General Harm Reduction

Testing Substances

Mixing Drugs

Warning: Combining depressants (alcohol, opioids, benzodiazepines) greatly increases overdose risk
Warning: Stimulants can mask alcohol's effects, leading to alcohol poisoning
Warning: MDMA + antidepressants = serotonin syndrome risk

Getting Help

---

References

  1. Hall W, Degenhardt L (2009). Should Burden of Disease Estimates Include Cannabis Use as a Risk Factor for Psychosis?. PLOS Medicine. [DOI]
  2. Yeung M, et al. (2024). A quantitative projection of the net health effects of cannabis legalization in the US. PLOS ONE. [DOI]
  3. MacCallum CA, et al. (2022). Lessons from 20 years of medical cannabis use in Canada. PLOS ONE. [DOI]
  4. Murphy PN, et al. (2016). Verbal Memory Impairment in Polydrug Ecstasy Users: A Clinical Perspective. PLOS ONE. [DOI]
  5. Kish SJ, et al. (2012). The Effects of Ecstasy (MDMA) on Brain Serotonin Transporters Are Dependent on Age-of-First Exposure. PLOS ONE. [DOI]
  6. White JM, Irvine RJ (2015). Understanding Heroin Overdose: A Study of the Acute Respiratory Depressant Effects of Injected Pharmaceutical Heroin. PLOS ONE. [DOI]
  7. Eap CB, et al. (2006). Determining Effective Methadone Doses for Individual Opioid-Dependent Patients. PLOS Medicine. [DOI]
  8. Rocha BA, et al. (2014). Cardiovascular Complications following Chronic Treatment with Cocaine and Testosterone in Adolescent Rats. PLOS ONE. [DOI]
  9. Todd G, et al. (2013). Illicit Stimulant Use Is Associated with Abnormal Substantia Nigra Morphology in Humans. PLOS ONE. [DOI]
  10. Ronsley C, et al. (2020). Treatment of stimulant use disorder: A systematic review of reviews. PLOS ONE. [DOI]
  11. Ross S, et al. (2024). Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for treatment of cancer-related psychological distress. PLOS Medicine. [DOI]
  12. Mathew AR, et al. (2020). A key indicator of nicotine dependence is associated with greater depression and anxiety. PLOS ONE. [DOI]
  13. Harlow AF, et al. (2025). Patterns of e-cigarette use and interest in cessation among current users. PLOS ONE. [DOI]